尼日利亚拉各斯的结核病和结核病-艾滋病防治公私混合模式。

Public-private mix for TB and TB-HIV care in Lagos, Nigeria.

机构信息

Department of Community Medicine and Primary Care, Olabisi Onabanjo University Teaching Hospital Sagamu, Ogun State, Nigeria.

出版信息

Int J Tuberc Lung Dis. 2013 Sep;17(9):1195-8. doi: 10.5588/ijtld.12.0759.

DOI:10.5588/ijtld.12.0759

PMID:23928168

Abstract

SETTING

Private and public tuberculosis (TB) treatment centres in Lagos State, Nigeria.

OBJECTIVE

To assess the contribution of private health care providers to TB and TB-HIV (human immunodeficiency virus) case finding in Lagos State.

DESIGN

A retrospective review of programme data submitted to the Lagos State TB and Leprosy Control Programme in 2011 by public, private for-profit (PFP) and private not-for-profit (PNFP) health care providers.

RESULTS

A total of 8425 TB cases were notified by 31 private (11 PFP and 20 PNFP) and 99 public health facilities in Lagos State. Overall, the private facilities were responsible for 10.3% (866/8425) of the total TB cases notified. The proportion of TB patients tested for HIV was respectively 86.2%, 53.1% and 96.5% among public, PFP and PNFP facilities. Overall, 22.4% of the TB patients were HIV-positive. The HIV positivity rate among public, PFP and PNFP facilities was respectively 23.8%, 7.8% and 9.9%. Uptake of cotrimoxazole preventive therapy was respectively 69.6%, 25% and 38.2% among public, PFP and PNFP facilities, while that of antiretroviral therapy was respectively 23.8%, 8.3% and 9.1% in public, PFP and PNFP facilities.

CONCLUSION

There is a need to scale up collaboration with the private sector, and particularly PNFP health providers.

摘要

背景

尼日利亚拉各斯州的私立和公立结核病（TB）治疗中心。

目的

评估私营医疗机构在拉各斯州发现结核病和结核病-艾滋病病毒（HIV）病例方面的贡献。

设计

对 2011 年拉各斯州结核病和麻风病控制计划向公共、营利性私营（PFP）和非营利性私营（PNFP）医疗机构提交的方案数据进行回顾性审查。

结果

共有 31 家私立（11 家 PFP 和 20 家 PNFP）和 99 家公立卫生机构向拉各斯州报告了 8425 例结核病病例。总体而言，私立医疗机构报告的结核病病例占总数的 10.3%（866/8425）。接受 HIV 检测的结核病患者比例分别为公立、PFP 和 PNFP 设施的 86.2%、53.1%和 96.5%。总体而言，22.4%的结核病患者 HIV 阳性。公立、PFP 和 PNFP 设施的 HIV 阳性率分别为 23.8%、7.8%和 9.9%。公立、PFP 和 PNFP 设施接受复方新诺明预防治疗的比例分别为 69.6%、25%和 38.2%，而接受抗逆转录病毒治疗的比例分别为 23.8%、8.3%和 9.1%。